Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting

S.M. Hermans; Y.C. Manabe; A.N. Kiragga; A.I.M. Hoepelman; J.M. Lange; F. van Leth

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting

Translated title of the contribution: Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting

S.M. Hermans
, Y.C. Manabe
, A.N. Kiragga
, A.I.M. Hoepelman
, J.M. Lange
, F. van Leth

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting
Original language	Undefined/Unknown
Pages (from-to)	615-622
Number of pages	8
Journal	Antiviral Therapy
Volume	18
Issue number	4
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23423604

Cite this

@article{7a59bcf656a54cc39ab19945d9e9fba9,

title = "Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting",

author = "S.M. Hermans and Y.C. Manabe and A.N. Kiragga and A.I.M. Hoepelman and J.M. Lange and \{van Leth\}, F.",

year = "2013",

language = "Undefined/Unknown",

volume = "18",

pages = "615--622",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "4",

}

TY - JOUR

T1 - Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting

AU - Hermans, S.M.

AU - Manabe, Y.C.

AU - Kiragga, A.N.

AU - Hoepelman, A.I.M.

AU - Lange, J.M.

AU - van Leth, F.

PY - 2013

Y1 - 2013

M3 - Article

SN - 1359-6535

VL - 18

SP - 615

EP - 622

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 4

ER -